13D Filing: Elliott Associates, L.p. and Mednax Inc. (NYSE:MD)

Page 3 of 8 – SEC Filing

1

NAME OF REPORTING PERSON

Elliott International, L.P.

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) x

(b) ¨

3 SEC USE ONLY
4

SOURCE OF FUNDS

WC

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

Cayman Islands, British West Indies

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:
7

SOLE VOTING POWER

0

8

SHARED VOTING POWER

1,098,879 (1)

9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

1,098,879 (1)

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

1,098,879 (1)

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

1.2%

14

TYPE OF REPORTING PERSON

PN

(1) Excludes cash-settled swaps disclosed in Item 6 representing
net economic exposure comparable to 1,832,215 additional shares of Common Stock, which if aggregated with such beneficially owned
shares, represent an aggregate economic interest in 2,931,094 shares representing 3.1% of the outstanding shares.

Follow Pediatrix Medical Group Inc. (NYSE:MD)